Every Form 4 that Avalon GloboCare Corp. (ALBT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ALBT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ALBT filings page.
Change Agents Corporation director Mathews Michael reported a preferred-for-common share conversion. On August 5, 2026 he disposed of 93.4200 shares of Series E Non-Voting Convertible Preferred Stock to the issuer at $1,000.0000 per share and acquired 62,280.0000 shares of Common Stock through conversion at a $1.5000 reference price. He now directly holds 1,271.4200 preferred shares and 62,280.0000 Common shares. The filing’s Rule 10b5-1 trading-plan box was unchecked.
Avalon GloboCare Corp. director Lu Wenzhao received a grant of 200,000 options to acquire Avalon GloboCare common stock. The options have an exercise price of $0.2820 per share and expire on June 29, 2029. All 200,000 options vest in full on the grant date, and this grant brings Lu’s reported derivative holdings from this award to 200,000 options held directly.
Avalon GloboCare Corp. director Steven Andrew Sanders received a grant of 200,000 options to purchase common stock. The options have an exercise price of $0.2820 per share and expire on June 29, 2029. According to the terms, all shares subject to the option vest in full on the grant date. Following this award, Sanders holds 202,132 derivative securities directly.
Avalon GloboCare Corp. director Michael Mathews received a grant of 100,000 stock options on June 29, 2026. The options have an exercise price of $0.2820 per share, are fully vested on the grant date, and are exercisable for Common Stock until June 29, 2029. Following this award, he holds 100,000 derivative securities directly.
Avalon GloboCare Corp. reported an equity compensation grant to Interim CEO Li Meng. On June 29, 2026, Meng received options to buy 400,000 shares of common stock at an exercise price of $0.282 per share. According to the terms, 100% of these options vested immediately on the grant date and they expire on June 29, 2029. Following this award, Meng holds 402,000 derivative securities directly.
Avalon GloboCare Corp. reported that Chief Strategy Officer Luisa Ingargiola received a grant of 400,000 stock options on June 29, 2026. The options have an exercise price of $0.2820 per share and expire on June 29, 2029. All shares underlying the option vested in full on the grant date. Following this award, Ingargiola holds 416,000 derivative securities directly.
Avalon GloboCare Corp. director Felix Lourdes reported a compensation-related equity award. He received options to purchase 100,000 shares of common stock on June 29, 2026, at an exercise price of $0.2820 per share. All option shares vested in full on the grant date. Following this grant, Lourdes holds 101,586 derivative option shares directly, which are scheduled to expire on June 29, 2029.
Avalon GloboCare Corp. director Michael Mathews reported receiving 1,364.840 shares of the company’s Series E Non-Voting Convertible Preferred Stock at a stated price of $0 per share. These preferred shares were issued in exchange for 2,600,000 common shares of RPM Interactive, Inc. as part of Avalon GloboCare’s acquisition of RPM.
Each share of this Series E preferred stock is perpetual, so it has no expiration date, and it becomes convertible into Avalon GloboCare equity at any time from and after May 12, 2026, or earlier if the company consents in writing.